Daxas 500 ug, Filmtabletten

7680604840023 CH-60484 Filmtabletten
Daxas 500 ug, Filmtabletten
Daxas 500 ug, Filmtabletten
Daxas 500 ug, Filmtabletten
1 / 3
google

Article details

Package size
90
Selling units
90
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/06/2026
Patient information leaflet
Français
10/06/2026
Patient information leaflet
Italien
10/06/2026
Summary of Product Characteristics
Allemand
10/06/2026
Summary of Product Characteristics
Français
10/06/2026
Summary of Product Characteristics
Italien
10/06/2026

Detailed composition

Substance Quantity Type Category
roflumilastum
500.0 UG Substance Wirkstoff (Principe actif)
lactosum monohydricum
198.64 MG Substance HBESI
maydis amylum
- Substance HNIDK
povidonum K 90
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 4000
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
60484
Drug name
Daxas, Filmtabletten
Galenic form
FILM
ATC Code
R03DX07
Authorization status
Z
Dispensing category
B
First authorization
18/11/2011
Authorization expiration date
31/12/9999
IT Number
03.04.5.
Domain
Human medicine
Field of application
COPD

Package details

Description (FR)
DAXAS cpr pell 500 mcg 90 pce
Description (DE)
DAXAS Filmtabl 500 mcg 90 Stk
Market launch
18/11/2011
Market withdrawal
28/05/2026
Narcotic (BTM)
No

Other package sizes (1)

DAXAS cpr pell 500 mcg 30 pce
30 TABL
GTIN: 7680604840016
View
Buy us a coffee Explore the data